Stock Events

Fresh2 

$0.34
7
+$0.02+5.63% Wednesday 17:03

統計

當日最高
-
當日最低
-
52週最高
4.45
52週最低
0.3
成交量
17,802
平均成交量
711,686
市值
2.86M
市盈率
0
股息收益率
-
股息
-

即將到來

收益

17May預期
Q1 2022
Q2 2022
Q3 2022
Q1 2023
Q3 2023
Q4 2023
Q1 2024
-3.6
-2.4
-1.2
0
預期每股收益
N/A
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 FRES 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. Further, it operates an e-commerce platform that connects food suppliers and supermarket operators and restaurant owners. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is based in New York, New York.
Show more...
首席執行官
Mr. Haohan Xu
員工
75
國家
US
ISIN
US03635R2067
WKN
000A3DWPG

上市公司